Generation Bio Q1 2024 Adj EPS $(1.12) Misses $(0.41) Estimate, Sales $4.059M Beat $1.920M Estimate
Generation Bio Q1 2024 Adj EPS $(1.12) Misses $(0.41) Estimate, Sales $4.059M Beat $1.920M Estimate
Generation Bio 2024年第一季度经调整后的每股收益美元（1.12）未达到预期（0.41）美元，销售额为405.9万美元，超过19.2亿美元的预期
Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(1.12) per share which missed the analyst consensus estimate of $(0.41) by 173.17 percent. The company reported quarterly sales of $4.059 million which beat the analyst consensus estimate of $1.920 million by 111.41 percent.
Generation Bio（纳斯达克股票代码：GBIO）公布的季度亏损为每股1.12美元，比分析师普遍预期的0.41美元（0.41美元）低173.17个百分点。该公司公布的季度销售额为405.9万美元，比分析师普遍预期的19.2万美元高出111.41％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。